Commit To Purchase Beam Therapeutics At $20, Earn 18.8% Annualized Using Options

Investors considering a purchase of Beam Therapeutics Inc (Symbol: BEAM) shares, but cautious about paying the going market price of $25.86/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in pa

admin